STEPHANIE GIONTA: Open Payments
NPI 1407575343 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 22 payments from 9 companies in 2025. Trend: 2023 $1,786 · 2024 $1,532 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $289 |
| Regeneron Healthcare Solutions, Inc. | 6 | $211 |
| ABBVIE INC. | 3 | $91 |
| Galderma Laboratories, L.P. | 4 | $76 |
| Arcutis Biotherapeutics, Inc. | 2 | $32 |
| Smith+Nephew, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Blueprint Medicines Corporation | 1 | $21 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, AYVAKIT, Zoryve, COLLAGENASE SANTYL, Rhapsido.
Industry payments across NY — which companies pay providers there.
